Summary With a prevalence of 4· 5%, infantile haemangiomas are the most common benign
tumours of infancy, arising in the first few weeks of life and exhibiting a characteristic …

Malignant vascular tumors as part of the vascular anomalies spectrum are extremely rare in
children and young adults. Instead, benign vascular neoplasias are frequently encountered …

Propranolol and atenolol, current therapies for problematic infantile hemangioma (IH), are
composed of R (+) and S (–) enantiomers: the R (+) enantiomer is largely devoid of beta …

Background Infantile haemangiomas (IH) are the most common vascular tumours of infancy.
Despite their frequency and potential complications, there are currently no unified UK …

Infantile hemangiomas (IH) are the most common tumors in children, with an estimated
incidence of 4% to 5%, with higher prevalence noted in Whites, girls, and preterm/low-birth …

Background Infantile hemangioma (IH) has received global attention, resulting in a
significant volume of literature. However, there is a lack of bibliometric analyses specifically …

Background A number of clinical trials evaluated the efficacy and adverse effects of oral
propranolol in the treatment of infantile hemangioma (IH), but the treatment has not yet been …

Infantile hemangiomas (IHs) are the most common benign tumor of infancy. As our
understanding of their pathobiology has evolved, treatment has become more focused and …

Although the efficacy of propranolol for the treatment of infantile hemangiomas (IHs) has
been well documented, there is a paucity of clinical data regarding the safety and tolerance …

Oral propranolol is the treatment of choice for infantile hemangiomas. The growth relapse
rate following oral propranolol therapy is not well established in the literature. The present …